Dataset for “When Does Pharma Corporate Venture Capital Accelerate IPO? Evidence across Financing Environments and Deal Structures in U.S. Biotech Firms”

This dataset accompanies the research article titled <i>“When Does Pharma Corporate Venture Capital Accelerate IPO?”</i> submitted to <i>PLOS ONE</i>.<br>The data include firm-level characteristics of 286 U.S. biotechnology firms founded between 1998 and 2015, observed through 2023.<br>Variables comprise investment type (Pharma CVC, Non-Pharma CVC, IVC), IPO outcomes, deal structures, firm age, financing timing, and market environment indicators.<br>Statistical analysis was performed using SPSS 31 and R (version 4.3.2), employing propensity score matching (PSM), logistic regression, and extended Cox proportional hazards models.<br>